Neuroimaging

Neuroimaging plays a pivotal role in understanding Alzheimer’s Disease and dementia by providing non-invasive methods to visualize brain structure and function. Techniques like MRI (Magnetic Resonance Imaging) reveal structural changes such as brain atrophy, a hallmark of Alzheimer’s. Functional MRI (fMRI) helps study brain activity patterns, highlighting areas affected by dementia-related cognitive decline. PET (Positron Emission Tomography) scans detect amyloid plaques and tau tangles, key pathological features in Alzheimer’s. These imaging tools aid in early diagnosis, tracking disease progression, and assessing treatment effectiveness. Advances in neuroimaging continue to refine our understanding of how Alzheimer’s alters the brain, offering hope for improved diagnostic accuracy and targeted therapeutic strategies.

Committee Members
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - London Jacqueline

London Jacqueline

Paris Diderot University, France
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease, Dementia & Cognitive Disorders Conference 2027 - Zhenhuan Liu

Zhenhuan Liu

Guangzhou University of Chinese Medicine, China

Submit your abstract Today

Whatsapp